pathology
revealed
News & Articles
Precision Histology: Artificial Intelligence as a Tool for Pathologists
The hematoxylin and eosin (H&E) stain has long been an essential tool in the pathologist’s arsenal. Positively-charged hematoxylin and negatively-charged eosin bind to different substances within a tissue sample. This allows pathologists to clearly view
United Nations: Making Global Goals Local Business
Athena, a voice for professional women in STEM in Southern California, recently became a signatory of the United Nations Global Compact. Athena joins over 9,933 companies in 160 countries focused on aligning their strategies and
BIOCOM EVENT: How is AI Benefiting Biopharma?
This BIOCOM event featured a full house with lively discussion as we learned about how Reveal Biosciences and Immuneering Corporation are applying Artificial Intelligence (AI) to benefit biopharma. The speakers were: Casey Laris, CTO, Reveal
Athena VLOG: Blueprint for Success
Meet our CEO, Dr. Claire Weston, chatting with Holly Smithson, CEO of Athena in their October Blueprint for Success video blog. Athena Mission: To empower progress together by advancing professional women in STEM. About Athena:
Mid-IR Microscopy for Biopharma
A Novel Class of Label-free Tissue Analysis Mid infrared (IR) microscopy is a well-established technique in spectroscopy and life sciences; however, until recently sample throughput and interpreting the large amount of data generated have been
Orthotopic PDX Models with Quantitative Pathology End Points in Translational Oncology Research
Orthotopic Patient-Derived Xenografts (PDX) Despite the rise of personalized approaches to the treatment of cancer, translating these therapies into a clinical setting still poses an exceptional challenge. This is highlighted in drug development where research
Certis Oncology Partners with Reveal Biosciences to Offer Advanced Pre-Clinical Oncology Services
SAN DIEGO, AUGUST 13, 2018. (GLOBE NEWSWIRE). Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an innovative, next-generation suite of pre-clinical oncology services.
Reveal Biosciences and Science Exchange Apply Artificial Intelligence to Pathology
PALO ALTO, Calif.–(BUSINESS WIRE)–Science Exchange, the leading marketplace for outsourced R&D™, announces a collaboration with Reveal Biosciences to offer on-demand access to AI-based pathology services worldwide. Reveal Biosciences is a San Diego-based company that’s leading the next generation
Case Study: Customized IHC Antibody Validation Services for Antibody Manufacturers
CASE STUDY Cancer R&D researchers have adopted the use of immunohistochemistry (IHC) tests for research, prognostic and diagnostic use at an extremely fast rate (1). Despite these statistics, many antibody vendors targeting these researchers do
Case Study: Customized IHC Antibody Optimization Services for Preclinical Research
CASE STUDY Researchers have adopted the use of immunohistochemistry (IHC) tests for research, prognostic and diagnostic use at an extremely fast rate (1). There are over 3 million commercially available antibodies; however, in a Nature
